Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BOLTBolt Biotherapeutics, Inc.

Nasdaq · CIK 0001641281
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts228

Identity from submissions API

NameBolt Biotherapeutics, Inc.
CIK0001641281
TickersBOLT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN472804636
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-665-9295
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Bolt Therapeutics, Inc. (2015-05-07T04:00:00.000Z → 2015-05-07T04:00:00.000Z)
Business address
900 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
CA
Mailing address
900 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

301 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 OWNERSHIP DOCUMENT 0001104659-26-129252 8945
2026-11-13 10-Q 10-Q 0001193125-26-458877 001-39988 261548470 34 11991401 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458403 001-39988 261547068 34 564655 1 1
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001037389-26-000063 005-92160 261546455 34 9479
2026-11-10 4 OWNERSHIP DOCUMENT 0001104659-26-125077 7288
2026-11-06 3 OWNERSHIP DOCUMENT 0001104659-26-124005 17997
2026-11-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-123999 005-92160 261533267 34 26525
2026-10-27 4 4 0001193125-26-434468 13473
2026-10-27 3 3 0001193125-26-434466 13159
2026-10-23 8-K 8-K 1.01,1.02,2.01,3.02,5.02,5.03,7.01,8.01,9.01 0001193125-26-429647 001-39988 261480446 34 12953092 1 1
2026-10-06 8-K 8-K 1.01 0001193125-26-415560 001-39988 261444084 34 159255 1 1
2026-09-21 4 4 0001193125-26-396894 9142
2026-09-21 4 4 0001193125-26-396892 10721
2026-09-21 4 4 0001193125-26-396890 10732
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001037389-26-000047 005-92160 261273784 34 9348
2026-08-11 10-Q 10-Q 0001193125-26-344597 001-39988 261263182 34 8639263 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344580 001-39988 261263113 34 536757 1 1
2026-06-11 4 4 0001193125-26-267560 5569
2026-06-11 4 4 0001193125-26-267558 5529
2026-06-11 4 4 0001193125-26-267546 5572
2026-06-11 4 4 0001193125-26-267533 5551
2026-06-11 4 4 0001193125-26-267518 5518
2026-06-11 8-K 8-K 5.07 0001193125-26-267487 001-39988 261083019 34 176283 1 1
2026-05-12 10-Q 10-Q 0001193125-26-219382 001-39988 26968480 34 7754975 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-219361 001-39988 26968407 34 485822 1 1
2026-04-28 ARS ARS 0001193125-26-186950 001-39988 26907708 34 63672621
2026-04-28 DEFA14A DEFA14A 0001193125-26-186940 001-39988 26907621 34 1342432 1 1
2026-04-28 DEF 14A DEF 14A 0001193125-26-186923 001-39988 26907566 34 2511163 1 1
2026-03-12 S-8 S-8 0001193125-26-104164 333-294245 26747897 33 433166 1 1
2026-03-12 10-K 10-K 0001193125-26-104121 001-39988 26747690 34 13575346 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-104102 001-39988 26747622 34 552304 1 1
2026-02-26 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001012975-26-000212 005-92160 26691577 34 62082
2026-02-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001012975-26-000173 005-92160 26644779 34 58577
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-016669 005-92160 26635363 34 13916
2026-02-04 4 4 0001193125-26-037697 7100
2026-02-04 4 4 0001193125-26-037692 5457
2026-02-04 4 4 0001193125-26-037690 7089
2025-12-16 4 4 0001193125-25-321156 20788
2025-12-16 4 4 0001193125-25-321154 32840
2025-12-16 4 4 0001193125-25-321153 24990
2025-12-16 4 4 0001193125-25-321152 33038
2025-12-16 4 4 0001193125-25-321150 28833
2025-12-16 4 4 0001193125-25-321149 42279
2025-12-16 4 4 0001193125-25-321148 55169
2025-12-16 4 4 0001193125-25-321146 38290
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-016687 005-92160 251486558 34 14164
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-016680 005-92160 251486437 34 14164
2025-11-12 10-Q 10-Q 0001193125-25-277549 001-39988 251472711 34 8736121 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-277521 001-39988 251472601 34 560796 1 1
2025-10-24 4 4 0001193125-25-250334 6626
2025-10-24 4 4 0001193125-25-250333 5097
2025-10-24 4 4 0001193125-25-250332 6667
2025-10-02 8-K 8-K 2.05,8.01 0001193125-25-228293 001-39988 251368928 34 205370 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-012265 005-92160 251219282 34 14300
2025-08-14 10-Q 10-Q 0001641281-25-000007 001-39988 251218986 34 8596974 1 1
2025-08-14 8-K 8-K 2.02,9.01 0001641281-25-000006 001-39988 251218792 34 559326 1 1
2025-07-02 4 4 0000950170-25-092941 5956
2025-07-02 4 4 0000950170-25-092940 5953
2025-07-02 4 4 0000950170-25-092939 5902
2025-07-02 4 4 0000950170-25-092938 5814
2025-07-02 4 4 0000950170-25-092937 5935
2025-06-06 8-K 8-K 3.01,5.03 0000950170-25-083180 001-39988 251031322 34 186924 1 1
2025-06-04 8-K 8-K 8.01 0000950170-25-081607 001-39988 251023098 34 157249 1 1
2025-05-28 8-K 8-K 5.07 0000950170-25-077880 001-39988 25990166 34 186887 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-007869 005-92160 25953329 34 28065
2025-05-12 10-Q 10-Q 0000950170-25-069188 001-39988 25934831 34 7578569 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-069153 001-39988 25934677 34 508442 1 1
2025-05-05 4 4 0000950170-25-063886 5390
2025-05-05 4 4 0000950170-25-063848 5450
2025-05-05 4 4 0000950170-25-063846 8559
2025-05-05 4 4 0000950170-25-063840 8599
2025-04-25 ARS ARS 0000950170-25-058668 001-39988 25873555 34 3707052
2025-04-25 DEF 14A DEF 14A 0000950170-25-058632 001-39988 25873523 34 4941354 1 1
2025-04-16 8-K 8-K 5.03,9.01 0000950170-25-054871 001-39988 25843630 34 464697 1 1
2025-04-16 PRE 14A PRE 14A 0000950170-25-054405 001-39988 25840890 34 1642396
2025-04-15 DEF 14A DEF 14A 0000950170-25-054294 001-39988 25840086 34 1642389
2025-03-24 S-8 S-8 0000950170-25-043900 333-286056 25764563 33 238573
2025-03-24 10-K 10-K 0000950170-25-043873 001-39988 25764484 34 12678134 1 1
2025-03-24 8-K 8-K 2.02,9.01 0000950170-25-043869 001-39988 25764473 34 547421 1 1
2025-01-03 8-K 8-K 3.01 0000950170-25-001159 001-39988 25506161 34 159108 1 1
2024-12-23 8-K 8-K 5.02 0000950170-24-139580 001-39988 241573701 34 154275 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118970 005-92160 241462709 34 136655
2024-11-12 10-Q 10-Q 0000950170-24-125413 001-39988 241448312 34 7168683 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125376 001-39988 241448127 34 450566 1 1
2024-09-06 4 xslF345X05/form4-09062024_040947.xml 0001415889-24-023005 8152
2024-09-06 3 xslF345X02/form3-09062024_040947.xml 0001415889-24-023004 9100
2024-09-04 8-K 8-K 5.02 0001193125-24-213225 001-39988 241278486 34 149276 1 1
2024-08-13 10-Q 10-Q 0000950170-24-096200 001-39988 241201500 34 7118439 1 1
2024-08-13 8-K 8-K 2.02,9.01 0000950170-24-096191 001-39988 241201451 34 443973 1 1
2024-07-24 4 4 0000950170-24-086153 5457
2024-07-24 4 4 0000950170-24-086146 5478
2024-07-24 4 4 0000950170-24-086136 7600
2024-07-03 8-K 8-K 3.01 0001193125-24-175113 001-39988 241100948 34 147117 1 1
2024-06-14 4 4 0000950170-24-073918 5394
2024-06-14 4 4 0000950170-24-073906 5392
2024-06-14 4 4 0000950170-24-073898 5425
2024-06-14 4 4 0000950170-24-073892 5456
2024-06-14 4 4 0000950170-24-073889 5304
2024-06-14 4 4 0000950170-24-073882 5401
2024-06-14 4 4 0000950170-24-073879 5443
2024-06-14 8-K 8-K 5.07 0000950170-24-073501 001-39988 241043986 34 170182 1 1
2024-05-20 DEFA14A DEFA14A 0000950170-24-062226 001-39988 24963559 34 29817
2024-05-15 3 3 0000950170-24-060630 24250
2024-05-14 10-Q 10-Q 0000950170-24-059564 001-39988 24944516 34 6387744 1 1
2024-05-14 8-K 8-K 2.01,2.05,5.02,9.01 0000950170-24-059524 001-39988 24944289 34 594604 1 1
2024-04-26 ARS ARS 0000950170-24-049111 001-39988 24883725 34 4139954
2024-04-26 DEFA14A DEFA14A 0000950170-24-049104 001-39988 24883671 34 2164560
2024-04-26 DEF 14A DEF 14A 0000950170-24-049095 001-39988 24883592 34 4904925
2024-03-21 S-8 S-8 0000950170-24-034711 333-278141 24771565 33 222417
2024-03-21 10-K 10-K 0000950170-24-034692 001-39988 24771437 34 10381901 1 1
2024-03-21 8-K 8-K 2.02,9.01 0000950170-24-034688 001-39988 24771378 34 437386 1 1
2024-03-06 4 4 0000950170-24-026999 5455
2024-03-06 4 4 0000950170-24-026998 5468
2024-03-06 4 4 0000950170-24-026997 5441
2024-03-06 4 4 0000950170-24-026996 5479
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023934 005-92160 24639956 34 136872
2024-02-14 SC 13G/A AMENDMENT NO.1 0001214659-24-002866 005-92160 24637369 34 77898
2024-02-13 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-013397 005-92160 24627540 34 115684
2024-02-12 SC 13D/A SC 13D/A 0001193125-24-032572 005-92160 24622352 34 180722
2024-02-06 5 FORM 5 SUBMISSION 0001209191-24-002901 4993
2024-02-06 5 FORM 5 SUBMISSION 0001209191-24-002899 6574
2024-02-06 5 FORM 5 SUBMISSION 0001209191-24-002897 6548
2023-12-13 4 FORM 4 SUBMISSION 0001209191-23-058458 7911
2023-12-01 4 FORM 4 SUBMISSION 0001209191-23-057049 12146
2023-11-22 4 FORM 4 SUBMISSION 0001209191-23-056548 8120
2023-11-22 4 xslF345X05/ownership.xml 0001213900-23-089692 21108
2023-11-20 4 FORM 4 SUBMISSION 0001209191-23-056185 16153
2023-11-20 4 xslF345X05/ownership.xml 0001213900-23-088909 32404
2023-11-09 10-Q 10-Q 0000950170-23-062048 001-39988 231392480 34 8055395 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062027 001-39988 231392402 34 550330 1 1
2023-08-07 10-Q 10-Q 0000950170-23-039061 001-39988 231147683 34 9077799 1 1
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-039047 001-39988 231147601 34 622847 1 1
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037117 5536
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037115 5539
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037113 5572
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037111 5589
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037109 5603
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037107 5451
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037104 5543
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037100 5563
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037097 5590
2023-06-13 8-K 8-K 5.07 0000950170-23-027743 001-39988 231011961 34 202189 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021233 001-39988 23911114 34 8100822 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021225 001-39988 23911044 34 575054 1 1
2023-04-28 ARS ARS 0000950170-23-015815 001-39988 23866373 34 1462281
2023-04-28 DEFA14A DEFA14A 0000950170-23-015796 001-39988 23866180 34 2846430
2023-04-28 DEF 14A DEF 14A 0000950170-23-015790 001-39988 23866114 34 7071080
2023-04-20 SC 13G r410233sc13g.htm 0001214659-23-005704 005-92160 23833241 34 85013
2023-03-29 S-8 S-8 0000950170-23-010624 333-270938 23775513 33 329347
2023-03-29 10-K 10-K 0000950170-23-010613 001-39988 23775391 34 12736791 1 1
2023-03-29 8-K 8-K 2.02,7.01 0000950170-23-010609 001-39988 23775349 34 716263 1 1
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013676 5572
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013674 5559
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013670 5585
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013666 5596
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020731 005-92160 23622649 34 137957
2023-02-13 SC 13G/A d9927317_13g-a.htm 0000919574-23-001028 005-92160 23616230 34 123430
2023-02-07 5 FORM 5 SUBMISSION 0001209191-23-007582 6446
2023-02-07 5 FORM 5 SUBMISSION 0001209191-23-007575 6433
2023-02-07 5 FORM 5 SUBMISSION 0001209191-23-007571 6461
2023-02-07 5 FORM 5 SUBMISSION 0001209191-23-007567 6472
2023-01-04 SC 13D/A SC 13D/A 0001193125-23-001509 005-92160 23506718 34 33374
2022-12-28 SC 13D/A SC 13D/A 0001193125-22-313666 005-92160 221494145 34 65489
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061591 5339
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061587 5243
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061584 8394
2022-12-16 3 FORM 3 SUBMISSION 0001209191-22-061581 7154
2022-12-14 8-K 8-K 5.02 0000950170-22-026551 001-39988 221462796 34 172974 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024487 001-39988 221377475 34 8502739 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024476 001-39988 221377340 34 664398 1 1
2022-09-30 SC 13D/A SC 13D/A 0001193125-22-255640 005-92160 221284674 34 61537
2022-08-10 10-Q 10-Q 0000950170-22-016460 001-39988 221151905 34 8243998 1 1
2022-08-10 8-K 8-K 2.02,9.01 0000950170-22-016454 001-39988 221151857 34 645444 1 1
2022-07-15 4 FORM 4 SUBMISSION 0001209191-22-042241 4784
2022-07-15 SC 13D/A SC 13D/A 0001193125-22-194922 005-92160 221086295 34 66069
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036090 5588
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036088 5591
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036086 5624
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036083 5641
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036081 5655
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036079 5503
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036077 5595
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036075 5615
2022-06-10 8-K 8-K 5.07 0000950170-22-011505 001-39988 221009869 34 198471 1 1
2022-05-16 SC 13G/A SC 13G/A 0001104659-22-061382 005-92160 22929816 34 78929
2022-05-12 10-Q 10-Q 0000950170-22-009664 001-39988 22917898 34 7521486 1 1
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009651 001-39988 22917804 34 570070 1 1
2022-04-28 DEFA14A DEFA14A 0000950170-22-006535 001-39988 22866622 34 1098133
2022-04-28 DEF 14A DEF 14A 0000950170-22-006528 001-39988 22866490 34 1683297
2022-04-07 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-07 16:00:00 9999999995-22-000871 333-263994 22815269 33 1781
2022-04-07 424B5 424B5 0001193125-22-099012 333-263994 22814606 33 337843
2022-04-06 UPLOAD filename1.pdf 0000000000-22-003680 40240
2022-04-05 CORRESP filename1.htm 0001193125-22-096156 7821
2022-03-30 S-3 S-3 0001193125-22-090029 333-263994 22787636 33 1578899
2022-03-30 S-8 2022 S-8 0001564590-22-012641 333-263987 22787178 33 238956
2022-03-30 10-K 10-K 0000950170-22-005047 001-39988 22786551 34 12965521 1 1
2022-03-30 8-K 8-K 2.02,9.01 0000950170-22-005040 001-39988 22786387 34 631477 1 1
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012466 8375
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012464 5532
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012463 8406
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012462 5644
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012459 8342
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012458 5670
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012456 5622
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012455 5629
2022-03-04 8-K 8-K 5.02,9.01 0000950170-22-002873 001-39988 22712214 34 295998 1 1
2022-02-23 4 FORM 4 SUBMISSION 0000899243-22-007526 5585
2022-02-23 4 FORM 4 SUBMISSION 0000899243-22-007525 5572
2022-02-23 4 FORM 4 SUBMISSION 0000899243-22-007524 5596
2022-02-23 4 FORM 4 SUBMISSION 0000899243-22-007520 5583
2022-02-23 4 FORM 4 SUBMISSION 0000899243-22-007519 5559
2022-02-14 SC 13G/A BOLT BIOTHERAPEUTICS, INC. 0001104659-22-021146 005-92160 22624601 34 139928
2022-02-01 4 FORM 4 SUBMISSION 0000899243-22-003917 10528
2022-01-25 8-K 8-K EIRGENIX AMENDMENT 1.01 0001564590-22-002321 001-39988 22553971 34 169967 1 1
2021-12-16 4 FORM 4 SUBMISSION 0000899243-21-048601 5708
2021-12-16 3 FORM 3 SUBMISSION 0000899243-21-048600 7408
2021-12-16 8-K 8-K NEW DIRECTOR ONETTO 5.02 0001564590-21-060502 001-39988 211496125 34 171719 1 1
2021-12-09 4 FORM 4 SUBMISSION 0000899243-21-047518 7876
2021-12-06 8-K 8-K BDC-1001 INTERIM DATA 7.01,9.01 0001564590-21-059379 001-39988 211472173 34 7825978 1 1
2021-11-29 SC 13G d9019577_13-g.htm 0000919574-21-007267 005-92160 211456740 34 112664
2021-11-22 SC 13D/A SC 13D/A 0001193125-21-336745 005-92160 211432508 34 63981
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065892 5769
2021-11-19 3 FORM 3 SUBMISSION 0001209191-21-065890 7168
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065887 5738
2021-11-19 3 FORM 3 SUBMISSION 0001209191-21-065884 7146
2021-11-19 8-K 8-K DIRECTOR APPOINTMENT 5.02 0001564590-21-057696 001-39988 211426401 34 173376 1 1
2021-11-09 10-Q Q3 2021 10-Q 0001564590-21-055774 001-39988 211392804 34 7803810 1 1
2021-11-09 8-K 8-K Q3'21 ER 2.02,9.01 0001564590-21-055698 001-39988 211391912 34 652303 1 1
2021-08-13 SC 13D/A SC 13D/A 0001193125-21-246211 005-92160 211173210 34 232900
2021-08-12 10-Q Q2'21 10-Q 0001564590-21-044002 001-39988 211167937 34 7540062 1 1
2021-08-12 8-K Q2'21 EPR 8-K 2.02,9.01 0001564590-21-043969 001-39988 211167627 34 651823 1 1
2021-06-07 D xslFormDX01/primary_doc.xml 06b 0001641281-21-000004 021-402021 211000410 33 15096
2021-06-02 8-K GENMAB AGREEMENT PRESS RELEASE 8-K 8.01,9.01 0001564590-21-031272 001-39988 21987712 34 231457 1 1
2021-05-13 10-Q 10-Q 0001564590-21-027545 001-39988 21919722 34 6342944 1 1
2021-05-13 8-K 8-K 2.02,9.01 0001564590-21-027527 001-39988 21919568 34 570736 1 1
2021-04-07 SC 13G SC 13G 0001104659-21-047573 005-92160 21812462 34 90365
2021-03-31 8-K 8-K 2.02,9.01 0001193125-21-102259 001-39988 21793322 34 127284
2021-03-31 10-K 10-K 0001193125-21-102253 001-39988 21793299 34 4597765
2021-02-19 SC 13G SC 13G 0001104659-21-025743 005-92160 21655569 34 170135
2021-02-18 SC 13G SCHEDULE 13G 0001213900-21-010349 005-92160 21650276 34 92393
2021-02-17 SC 13D SC 13D 0001193125-21-046616 005-92160 21645733 34 103537
2021-02-16 SC 13D SC 13D 0001104659-21-023629 005-92160 21636132 34 108891
2021-02-11 4 FORM 4 SUBMISSION 0001209191-21-009720 16054
2021-02-11 SC 13D SC 13D 0001193125-21-038571 005-92160 21620283 34 115665
2021-02-09 4 OWNERSHIP DOCUMENT 0001104659-21-016806 18225
2021-02-09 8-K 8-K 5.03,9.01 0001193125-21-034375 001-39988 21606675 34 48181
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008758 71282
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008756 4418
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008753 18512
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008750 13862
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008747 6180
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008744 48076
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008741 4654
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008739 4598
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008533 5571
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008529 5584
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008527 5582
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008521 5613
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008516 5558
2021-02-05 S-8 S-8 0001193125-21-030982 333-252815 21597473 33 99654
2021-02-05 424B4 424B4 0001193125-21-030767 333-252136 21596623 33 5215819
2021-02-04 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-02-04 16:00:00 9999999995-21-000441 333-252136 21593279 33 1781
2021-02-04 S-1MEF S-1MEF 0001193125-21-029328 333-252762 21593244 33 55340
2021-02-04 3 OWNERSHIP DOCUMENT 0001104659-21-012449 20989
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007904 10573
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007902 27396
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007860 7988
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007858 12535
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007856 10235
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007853 8717
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007843 8538
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007838 24311
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007835 6577
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007833 16970
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007827 15978
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007826 8705
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007823 11552
2021-02-04 3 FORM 3 SUBMISSION 0001209191-21-007819 11704
2021-02-04 CERT 8A_Cert_BOLT.pdf 0001354457-21-000163 001-39988 21589942 34 198937
2021-02-03 SEC STAFF LETTER filename1.pdf 9999999997-21-000541 392502
2021-02-03 S-1/A AMENDMENT NO 2 TO FORM S-1 0001193125-21-027469 333-252136 21587405 33 5078464
2021-02-02 CORRESP filename1.htm 0001193125-21-025787 11244
2021-02-02 CORRESP filename1.htm 0001193125-21-025785 8809
2021-02-02 8-A12B 8-A12B 0001193125-21-025784 001-39988 21580949 34 15054
2021-02-01 S-1/A AMENDMENT NO 1 TO FORM S-1 0001193125-21-023574 333-252136 21574226 33 5820057
2021-01-28 D xslFormDX01/primary_doc.xml 06b 0001641281-21-000003 021-387686 21563701 33 14266
2021-01-25 CORRESP filename1.htm 0001193125-21-016649 132256
2021-01-15 S-1 S-1 0001193125-21-010049 333-252136 21532076 33 24430999
2021-01-11 DRSLTR filename1.htm 0000950123-21-000227 18984
2021-01-11 DRS/A filename1.htm 0000950123-21-000224 377-03397 21521400 33 5743758
2020-09-17 UPLOAD filename1.pdf 0000000000-20-008771 43128
2020-09-15 SEC STAFF LETTER filename1.pdf 9999999997-21-000665 154038
2020-09-11 DRS/A filename1.htm 0000950123-20-009639 377-03397 201169741 33 22896570
2020-09-10 DRSLTR filename1.htm 0000950123-20-009640 39914
2020-09-01 UPLOAD filename1.pdf 0000000000-20-008238 58325
2020-08-10 DRS filename1.htm 0000950123-20-008057 377-03397 201089103 33 4574037
2019-07-15 D xslFormDX01/primary_doc.xml 06b 0001641281-19-000002 021-344279 19954698 33 9615
2018-08-06 D xslFormDX01/primary_doc.xml 06b 0001641281-18-000004 021-318563 18994571 33 8823
2018-02-20 D xslFormDX01/primary_doc.xml 06b 0001641281-18-000001 021-306025 18624756 33 8880
2016-09-30 D xslFormDX01/primary_doc.xml 06b 0001641281-16-000005 021-271607 161911129 33 8903
2015-05-07 D xslFormDX01/primary_doc.xml 06b 0001641281-15-000001 021-239337 15838897 33 6567

Latest XBRL company facts

One latest value per concept from companyfacts (228 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.61M 2026-11-06 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
dei EntityPublicFloat Entity Public Float USD 7.30M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 633,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 132,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -43,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 488.93M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 507,827 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 808,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap Assets Assets USD 35.59M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AssetsCurrent Assets, Current USD 17.08M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641281-25-000007
us-gaap CapitalizedComputerSoftwareAccumulatedAmortization Capitalized Computer Software, Accumulated Amortization USD 200,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 13.78M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 15.52M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 15.52M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.07 2018-07-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 817,995 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -19.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 3.10M 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034692
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.40M 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034692
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 2.36M 2020-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 924,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 110,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 109.25M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 21.55M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 5.66M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 66.02M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 12.17M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 2.24M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 551,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 103.59M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 5.66M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 51,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 73,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap Depreciation Depreciation USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 440,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -10.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.25 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016460
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -10.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.197 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 451,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 800,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016460
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016460
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016460
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016460
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 21,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055774
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -108,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 288,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 245,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ImpairedFinancingReceivableRelatedAllowance Impaired Financing Receivable, Related Allowance USD 0 2024-03-31 2024 Q1 10-Q 2024-05-14 0000950170-24-059564
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-06-01 2024-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -31.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -33.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -1.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 6.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -161,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -7.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 492,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 620,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 513,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -593,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 8,826 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap InvestmentIncomeNet Investment Income, Net USD 599,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 4.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 27.49M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.61M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.58M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.18M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.18M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 5.97M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.78M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.37M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6.60M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap Liabilities Liabilities USD 27.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 35.59M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.31M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap LongTermInvestments Long-term Investments USD 247,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 321,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 25,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 19.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -17.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -19.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap OperatingExpenses Operating Expenses USD 20.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -20.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2024-06-01 2024-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 20.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.23M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 17.66M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 16.37M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.119 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 1,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 18,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -22,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherExpenses Other Expenses USD 440,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 4.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherIncome Other Income USD 557,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 1.52M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344597
us-gaap PaymentsForRestructuring Payments for Restructuring USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125413
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125413
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125413
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125413
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125413
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap PrepaidRent Prepaid Rent USD 564,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 244.32M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 51.90M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 20.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 722,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -19.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.16M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 341,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 12.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.54M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 3.60M 2024-05-14 2024 Q2 10-Q 2024-08-13 0000950170-24-096200
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.5 2024-05-14 2025 Q3 10-Q 2025-11-12 0001193125-25-277549
us-gaap RestructuringCharges Restructuring Charges USD 1.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap RestructuringReserve Restructuring Reserve USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277549
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD 54,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277549
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-096200
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -480.33M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap Revenues Revenues USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.91 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.87 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.042 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 3.32M 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 354,334 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 7.37 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 242,496 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 130,963 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.14 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 249,500 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 12,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 459,775 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.93 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 9,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 12,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 459,775 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.93 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.10M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043873
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043873
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 36.84 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.95 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap ShortTermInvestments Short-term Investments USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 249,218 2018-07-01 2018-07-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 8.56M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 20 2025-06-06 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 4,778 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 188.51M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 241.96M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap SubleaseIncome Sublease Income USD 1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024487
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-30 0000950170-22-005047
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 26.77M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 375,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043873
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 2.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 4.14M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010613
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104121
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.21M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016460
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2026-01-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458877

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →